VEGFD and lymphangioleiomyomatosis: The circulating level of VEGF-D was significantly higher in LAM patients compared to controls (Fig. 1) with a VEGF-D level above 800 pg/ml in 82% (23/28) of LAM patients (and over 4000 pg/ml VEGF-D for four patients).